Author:
Zhou Qiang,Xiao Jianmin,Jiang Dawei,Wang Ruiwu,Vembaiyan Kannan,Wang Aixia,Smith Chris D,Xie Cuihong,Chen Wenqian,Zhang Jingqun,Tian Xixi,Jones Peter P,Zhong Xiaowei,Guo Ang,Chen Haiyan,Zhang Lin,Zhu Weizhong,Yang Dongmei,Li Xiaodong,Chen Ju,Gillis Anne M,Duff Henry J,Cheng Heping,Feldman Arthur M,Song Long-Sheng,Fill Michael,Back Thomas G,Chen S R Wayne
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference53 articles.
1. Waldo, A.L. et al. Effect of D-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral D-Sotalol. Lancet 348, 7–12 (1996).
2. Miller, L.W. Limitations of current medical therapies for the treatment of heart failure. Rev. Cardiovasc. Med. 4 (Suppl. 2), S21–S29 (2003).
3. Kamath, G.S. & Mittal, S. The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death. Prog. Cardiovasc. Dis. 50, 439–448 (2008).
4. Poole-Wilson, P.A. et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362, 7–13 (2003).
5. Stroe, A.F. & Gheorghiade, M. Carvedilol: beta-blockade and beyond. Rev. Cardiovasc. Med. 5 (Suppl. 1), S18–S27 (2004).
Cited by
205 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献